Edwards Lifesciences · Total Non-Current Liabilities

EW Total Non-Current Liabilities

Latest reported$1.63Bperiod endingJun 30, 2026

EW Quarterly Total Non-Current Liabilities ($57.00M → $1.63B)

Quarterly total non-current liabilities

High-resolution chart · PNG

EW total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2026	1,634,300,000
Mar 31, 2026	1,584,699,999
Dec 31, 2025	1,545,900,000
Sep 30, 2025	1,479,200,000
Jun 30, 2025	1,477,500,000
Mar 31, 2025	1,435,900,000
Dec 31, 2024	1,487,200,000
Sep 30, 2024	1,415,700,000
Jun 30, 2024	1,377,700,000
Mar 31, 2024	1,439,100,000
Dec 31, 2023	1,448,400,000
Sep 30, 2023	1,404,800,000
Jun 30, 2023	1,400,300,000
Mar 31, 2023	1,507,200,000
Dec 31, 2022	1,463,400,000
Sep 30, 2022	1,502,500,000
Jun 30, 2022	1,512,400,000
Mar 31, 2022	1,625,100,000
Dec 31, 2021	1,634,400,000
Sep 30, 2021	1,652,500,000
Jun 30, 2021	1,642,600,000
Mar 31, 2021	1,756,300,000
Dec 31, 2020	1,768,900,000
Sep 30, 2020	1,744,200,000
Jun 30, 2020	1,711,800,000
Mar 31, 2020	1,428,100,000
Dec 31, 2019	1,437,400,000
Sep 30, 2019	1,375,700,000
Jun 30, 2019	1,376,200,000
Mar 31, 2019	1,375,300,000
Dec 31, 2018	1,306,700,000
Sep 30, 2018	1,335,800,000
Jun 30, 2018	1,338,700,000
Mar 31, 2018	1,264,900,000
Dec 31, 2017	1,302,400,000
Sep 30, 2017	1,590,700,000
Jun 30, 2017	1,636,400,000
Mar 31, 2017	1,452,900,000
Dec 31, 2016	1,358,500,000
Sep 30, 2016	1,114,400,000
Jun 30, 2016	1,102,000,000
Mar 31, 2016	1,096,200,000
Dec 31, 2015	1,080,000,000
Sep 30, 2015	922,700,000
Jun 30, 2015	874,500,000
Mar 31, 2015	869,200,000
Dec 31, 2014	898,500,000
Sep 30, 2014	878,800,000
Jun 30, 2014	871,200,000
Mar 31, 2014	954,700,000
Dec 31, 2013	819,900,000
Sep 30, 2013	758,100,000
Jun 30, 2013	445,700,000
Mar 31, 2013	404,200,000
Dec 31, 2012	394,800,000
Sep 30, 2012	360,900,000
Jun 30, 2012	356,200,000
Mar 31, 2012	348,700,000
Dec 31, 2011	307,400,000
Sep 30, 2011	326,300,000
Jun 30, 2011	303,900,000
Mar 31, 2011	128,100,000
Dec 31, 2010	121,200,000
Sep 30, 2010	210,300,000
Jun 30, 2010	276,400,000
Mar 31, 2010	210,700,000
Dec 31, 2009	167,100,000
Sep 30, 2009	215,400,000
Jun 30, 2009	216,900,000
Mar 31, 2009	215,400,000
Dec 31, 2008	262,900,000
Sep 30, 2008	276,800,000
Jun 30, 2008	224,400,000
Mar 31, 2008	141,100,000
Dec 31, 2007	134,700,000
Sep 30, 2007	127,100,000
Jun 30, 2007	120,700,000
Mar 31, 2007	284,800,000
Dec 31, 2006	271,200,000
Sep 30, 2006	284,900,000
Jun 30, 2006	310,300,000
Mar 31, 2006	319,000,000
Dec 31, 2005	344,900,000
Sep 30, 2005	281,200,000
Jun 30, 2005	298,700,000
Mar 31, 2005	298,600,000
Dec 31, 2004	289,200,000
Sep 30, 2004	302,300,000
Jun 30, 2004	347,400,000
Mar 31, 2004	377,200,000
Dec 31, 2003	299,100,000
Sep 30, 2003	320,100,000
Jun 30, 2003	334,600,000
Mar 31, 2003	303,300,000
Dec 31, 2002	270,900,000
Sep 30, 2002	284,600,000
Jun 30, 2002	317,600,000
Mar 31, 2002	311,300,000
Dec 31, 2001	330,000,000
Sep 30, 2001	389,600,000